Ozempic (GLP-1) NAION Lawsuit
Choose Flint Cooper’s team of Ozempic NAION attorneys to listen to your unique story and provide meaningful benefits for you and your family.
Schedule a Free Consultation
Schedule a Free Consultation
Ozempic (GLP-1) NAION Lawsuit
At Flint Cooper, we are committed to upholding the rights of those who have experienced unexpected and life-altering injuries after taking Ozempic and other GLP-1 medications. A growing number of patients prescribed these drugs, whether for Type 2 diabetes or weight management, have reported suffering non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden and permanent vision loss.
If you or a loved one developed vision loss after using a GLP-1 medication, you may be entitled to compensation. Flint Cooper is actively investigating NAION cases nationwide and is ready to help you understand your legal options.
GLP-1 drugs like Ozempic were widely prescribed without adequate warnings about the risk of severe vision loss. When patients suffer permanent eye damage without being properly informed, that breakdown in drug safety and transparency cannot be overlooked.
Trent Miracle
Partner, Mass Torts
$2,000,000,000+
Understanding the Ozempic NAION Litigation
Ozempic (semaglutide) belongs to a class of drugs known as GLP-1 receptor agonists, which also includes Wegovy, Rybelsus, Mounjaro, Trulicity and others. These medications help regulate blood sugar, support weight loss and are widely prescribed across the United States.
However, recent medical research has raised concerns that GLP-1 drugs may increase the risk of NAION, a serious optic nerve injury caused by reduced blood flow to the eye. NAION can result in partial or total, often permanent, vision loss in one or both eyes.
Current lawsuits allege that drug manufacturers failed to properly warn doctors and patients about the risk of NAION, leaving many individuals affected by sudden vision problems they could not have anticipated.
If you experienced vision changes, especially sudden or unexplained vision loss, after taking Ozempic or another GLP-1 medication, it is important to speak with an attorney as soon as possible.
Who Qualifies to File an Ozempic NAION Lawsuit?
You may qualify for an Ozempic NAION lawsuit if you meet all of the following criteria:
- Prescription use of Ozempic, Rybelsus or Wegovy (semaglutide)
- Prescription use of Trulicity (dulaglutide) and/or Mounjaro (tirzepatide)
- Diagnosed vision loss, with a confirmed diagnosis of NAION
- Statute of limitations beginning July 2024 or later
If you are unsure whether you qualify, our team can review your medical history and provide clear guidance during your free consultation.
Symptoms and Risks of NAION
NAION often appears suddenly and may include:
- Blurred or dim vision
- Loss of vision in one eye
- Visual field defects
- Reduced Color Perception
Unlike some optic nerve injuries, NAION damage is frequently permanent, making early recognition and legal action especially critical.
How Flint Cooper Can Help
Pharmaceutical litigation is complex, but you do not have to navigate it alone. Flint Cooper is equipped to guide clients through every step of the process, from investigation and case development to pursuing compensation for:
- Medical bills
- Vision treatment or rehabilitation
- Loss of independence
- Lost income or reduced earning capacity
- Pain and suffering
We operate on a contingency fee basis, meaning you pay nothing unless we win your case. Our team remains committed to holding corporations accountable when patients are injured by inadequate warnings or insufficient safety disclosures.
To schedule a free consultation, please call +1 618.288.4777.
Practice Areas
Asbestos
Mass Torts
Personal Injury
